Question 1

What is Tubulis?

Accepted Answer

Tubulis is a Entity.

Question 2

How often does Tubulis appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Tubulis first tracked by Ergen?

Accepted Answer

First tracked on Apr 07, 2026.

Question 4

When was Tubulis last mentioned in news?

Accepted Answer

Last active on May 15, 2026.

Question 5

What is Tubulis's current news sentiment?

Accepted Answer

Aggregate sentiment score: 85 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Tubulis in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Tubulis?

Accepted Answer

Gilead Sciences Acquires Tubulis for $5B (Apr 07, 2026, 6 articles).

Question 8

How did the "Gilead Sciences Acquires Tubulis for $5B" event impact Tubulis?

Accepted Answer

Tubulis, a clinical-stage biotechnology company, is being acquired by Gilead Sciences for up to $5.0 billion, allowing it to accelerate the development of its ADC pipeline.

Question 9

How did the "Gilead Sciences Acquires Tubulis" event impact Tubulis?

Accepted Answer

Tubulis is being acquired by Gilead Sciences for $3.15 billion upfront and up to $1.85 billion in milestone payments. It will operate as a dedicated ADC research organization within Gilead Sciences, serving as a hub for innovation.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.